Workers' Comp
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
May 7, 2020
MIN READ
More stories
Mitchell
News Release
Mitchell Issues Third Quarter 2018 Industry Trends Report
The Latest Technology Trends, Industry Insights, Data and Analyses on the Property & Casualty and Collision Repair Industries
Mitchell
News Release
California Updates MTUS Drug Formulary
California updated its MTUS formulary to align more closely with treatment and opioid prescribing guidelines.
Mitchell
Article
10 Tips Every Estimator Should Be Following
Today more than ever, the importance of creating an outstanding blueprint for automotive repair is an integral part of Proper and Safe repairs. Creating a roadmap of how the vehicle is going to be repaired provides the most accurate and efficient methods of repair and ensures that every standard operating procedure (SOP) is being met.
Workers' Comp
Article
StateWatch: Bill Review August / September 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
Implications of Epidiolex FDA Approval on Workers' Compensation
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
Workers' Comp
Blog
How Differences in Claim Age and Population Affect Opioid Trends
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.